Article info
Original article
Hyaluronan synthase 2 is an adverse prognostic marker in androgen receptor-negative breast cancer
- Correspondence to Dr Gary M Tse, Department of Anatomical and Cellular Pathology, Prince of Wales Hospital, Ngan Shing Street, Shatin, NT, Hong Kong; garytse{at}cuhk.edu.hk
Citation
Hyaluronan synthase 2 is an adverse prognostic marker in androgen receptor-negative breast cancer
Publication history
- Received January 8, 2016
- Revised April 6, 2016
- Accepted April 24, 2016
- First published May 11, 2016.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/